Novel dihydropyrimidines as promising EGFR & HER2 inhibitors: Insights from experimental and computational studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel dihydropyrimidines as promising EGFR & HER2 inhibitors: Insights from experimental and computational studies

Published:2024-09 Issue: Volume:275 Page:116607
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Faizan Syed,Wali Adil Farooq,Talath Sirajunisa,Rehman Muneeb U.,Sivamani Yuvaraj,Nilugal Kiran C.,Shivangere Narendra Babu,Attia Sabry M.,Nadeem Ahmed,Elayaperumal Sumitha,Kumar B.R. Prashantha

Funder

ICMR

Publisher

Elsevier BV

Reference65 articles.

1. The drug-target residence time model: a 10-year retrospective;Copeland;Nat. Rev. Drug Discov.,2016

2. Finding the sweet spot: the role of nature and nurture in medicinal chemistry;Hann;Nat. Rev. Drug Discov.,2012

3. Principles of early drug discovery;Hughes;Br. J. Pharmacol.,2011

4. Novel derivatives of eugenol as potent anti-inflammatory agents via PPARγ agonism: rational design, synthesis, analysis, PPARγ protein binding assay and computational studies;Anjum;RSC Adv.,2022

5. Multicomponent mechanochemical synthesis;Leonardi;Chem. Sci.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP